Single dose of Johnson & Johnson vaccine is 66% effective, say U.S. regulators February 24, 2021 Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration staff said in documents published on Wednesday, paving the way for its approval for emergency use. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.